Fatal pulmonary mucormycosis caused by rhizopus microsporus in a patient with diabetes

Annals of Laboratory Medicine

Volumn 34, Issue 1, 2014, Pages 76-79

  Kim, Moon Jin ^a   Park, Pil Whan ^a   Ahn, Jeong Yeal ^a   Kim, Kyung Hee ^a   Seo, Ja Young ^a   Jeong, Ji Hun ^a   Park, Mi Jung ^a   Jung, Jin Woo ^a   Seo, Yiel Hea ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

RIBOSOME DNA;

CASE REPORT; CHEMISTRY; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; FATALITY; HUMAN; ISOLATION AND PURIFICATION; LETTER; MALE; MICROBIOLOGY; MUCORMYCOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; RHIZOPUS; SEQUENCE HOMOLOGY; VERY ELDERLY;

AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; DNA, RIBOSOMAL; FATAL OUTCOME; HUMANS; MALE; MUCORMYCOSIS; RHIZOPUS; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84893358324     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2014.34.1.76     Document Type: Letter

References (13)

1. Garcia-Hermoso D, Dannaoui E, Lortholary O, Dromer F. Agents of systemic and subcutaneous mucormycosis and entomophthoromycosis. In: Versalovic J, Carroll KC, Funke G, Jorgensen JH, Landry ML, Warnock DW, eds. Manual of clinical microbiology. 10th ed. Washington, DC: ASM press, 2011:1880-901.
2. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012;54(S1):S16-22.
3. Hamilos G, Samonis G, Kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med 2011;32:693-702.
4. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev 2000;13:236-301.
5. Schwarz P, Bretagne S, Gantier J-C, Garcia-Hermoso D, Lortholary O, Dromer F, et al. Molecular identification of zygomycetes from culture and experimentally infected tissues. J Clin Microbiol 2006;44:340-9.
6. Park Y and Min B. Sequence analysis of the internal transcribed spacer of ribosomal DNA in the genus Rhizopus. Mycobiology 2005;33:109-12.
7. Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, et al. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: A case-control observational study of 27 recent cases. J Infect Dis 2005;191:1350-60.
8. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: A review of 929 reported cases. Clin Infect Dis 2005;41:634-53.
9. Garg J, Sujatha S, Garg A, Parija SC. Nosocomial cutaneous zygomycosis in a patient with diabetic ketoacidosis. Int J Infect Dis 2009;13:e508-10.
10. de Mol P and Meis JF. Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: A case report. Neth J Med 2009;67:25-8.
11. Vigouroux S, Morin O, Moreau P, Méchinaud F, Morineau N, Mahé B, et al. Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: Attention required. Clin Infect Dis 2005;40:e35-7.
12. Balajee SA, Borman AM, Brandt ME, Cano J, Cuenca-Estrella M, Dannaoui E, et al. Sequence-based identification of aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: Where are we and where should we go from here? J Clin Microbiol 2009;47:877-84.
13. Alvarez E, Sutton DA, Cano J, Fothergill AW, Stchigel A, Rinaldi MG, et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol 2009;47:1650-6